Were you diagnosed with NAION after taking Ozempic, Wegovy, Rybelsus, or another GLP-1 medication?

Prescription medications used to manage diabetes and weight loss have come under increased scrutiny following reports of serious vision complications. Research has identified a potential connection between GLP-1 medications and non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition that can cause sudden, permanent vision loss.

For Birmingham residents who developed NAION after taking Ozempic, Wegovy, Rybelsus, or another GLP-1 medication, understanding the potential health risks and legal options is an important next step.

The Birmingham dangerous drug lawyers at Morris Bart can review your medical history, evaluate the circumstances surrounding your diagnosis, and help determine whether you may have grounds to pursue compensation.

What is the Latest Update for GLP-1 NAION Lawsuits?

On November 9, 2026, the U.S. Food and Drug Administration (FDA) announced that manufacturers of GLP-1 receptor agonist medications must update their product labeling to include warnings about a potential increased risk of NAION.

The announcement follows an extensive review of clinical trials, observational studies, and reports of vision loss among patients taking these medications.

The FDA’s analysis of 126 randomized clinical trials found:

6.4 NAION cases per 100,000 person-years among patients taking GLP-1 medications.
3.8 NAION cases per 100,000 person-years among patients receiving a placebo or another non-GLP-1 diabetes medication.

While these findings do not establish that GLP-1 medications caused every reported case of NAION, they represent an important development in understanding the potential risks associated with these drugs.

The new warning requirements apply to GLP-1 medications including Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound.

For Alabama residents who experienced vision loss after using these medications, the updated FDA guidance may be relevant when evaluating a potential dangerous drug claim.

For a free legal consultation with a lawyer serving Alabama, call 800-537-8185

Can You File a GLP-1 NAION Lawsuit in Birmingham, AL?

Patients who developed NAION after taking certain GLP-1 medications have filed lawsuits alleging that drug manufacturers failed to adequately warn consumers and healthcare providers about potential vision-related risks.

Federal GLP-1 NAION lawsuits have been consolidated into multidistrict litigation (MDL No. 3163) in the U.S. District Court for the Eastern District of Pennsylvania.

Although these federal cases are being coordinated outside Alabama, Birmingham residents may still have the opportunity to pursue legal action. Whether a claim qualifies for inclusion in the litigation depends on the medication involved, medical evidence, applicable legal requirements, and other individual circumstances.

If you were diagnosed with NAION after taking a GLP-1 medication, an attorney can help you understand how the ongoing litigation may affect your potential claim.

Which GLP-1 Medications Have Been Linked to NAION?

GLP-1 receptor agonists are prescription medications that mimic a naturally occurring hormone involved in blood sugar regulation and appetite control. They are commonly prescribed to manage type 2 diabetes and, depending on the medication, chronic weight management.

Several widely used medications contain semaglutide, including:

Ozempic: An injectable semaglutide medication primarily used to manage type 2 diabetes.
Wegovy: A semaglutide medication approved for chronic weight management and certain additional indications.
Rybelsus: An oral semaglutide medication used to treat type 2 diabetes.

Other GLP-1-based medications, including Mounjaro and Zepbound, contain tirzepatide, which acts on both GLP-1 and GIP receptors.

In 2025, European regulators recognized NAION as a very rare side effect of semaglutide medications. The FDA’s November 2026 announcement expanded the warning requirement to GLP-1 receptor agonists as a class.

Although these medications provide important benefits for many patients, the emerging safety information has raised questions about whether consumers received adequate warnings about potentially serious vision complications.

Click to contact our Birmingham Dangerous Drug Attorney today

What is NAION and Why Can It Cause Permanent Vision Loss?

Non-arteritic anterior ischemic optic neuropathy (NAION) is a condition that develops when blood flow to the front portion of the optic nerve becomes insufficient.

The optic nerve is responsible for transmitting visual information from the eye to the brain. When its blood supply is disrupted, damage can occur suddenly, sometimes resulting in permanent loss of vision.

Unlike eye conditions that develop gradually, NAION frequently occurs without pain or noticeable warning signs. Some patients first discover the problem when they wake up and notice that part of their vision is missing or distorted.

NAION typically affects one eye initially, although the other eye may also be affected later.

The condition is associated with several underlying health factors, including diabetes, high blood pressure, sleep apnea, and certain cardiovascular conditions. Researchers continue to investigate how GLP-1 medications may contribute to the risk.

What Are the Symptoms of NAION?

Recognizing the symptoms of NAION is important because sudden vision changes require immediate medical evaluation.

Potential warning signs include:

Sudden, painless vision loss in one eye
Blurred, hazy, or dimmed eyesight
Dark spots or missing areas within the visual field
Reduced peripheral or central vision
Difficulty seeing objects in the upper or lower field of vision
Changes in color perception or contrast sensitivity

Not all vision changes experienced while taking GLP-1 medications are caused by NAION. Other medical conditions can produce similar symptoms, making an examination by an ophthalmologist or another qualified medical professional essential.

Anyone experiencing sudden or rapidly worsening vision loss should seek immediate medical attention.

Who May Qualify for a GLP-1 NAION Lawsuit in Alabama?

A diagnosis of NAION following GLP-1 medication use does not automatically establish that the medication caused the condition or that a patient has a valid legal claim.

However, certain circumstances may warrant further investigation.

When evaluating a potential GLP-1 NAION lawsuit, a Birmingham dangerous drug attorney may review:

Prescription history: Which GLP-1 medication was used, including the dosage and duration of treatment.
Medical diagnosis: Whether NAION was formally diagnosed by an ophthalmologist or other qualified specialist.
Timeline of symptoms: When vision problems began in relation to medication use.
Medical records: Documentation of eye examinations, diagnostic testing, and related treatment.
Preexisting conditions: Whether diabetes, hypertension, sleep apnea, or other health factors may have contributed to the injury.
Impact of vision loss: How the condition has affected the patient’s employment, independence, finances, and quality of life.

These details can help an attorney assess whether the available evidence supports pursuing a claim against a drug manufacturer.

What Compensation May Be Available in a GLP-1 Vision Loss Lawsuit?

Vision loss can affect far more than a person’s eyesight. For some individuals, permanent damage to the optic nerve may interfere with employment, driving, reading, and other activities that were once part of everyday life.

Depending on the circumstances of the case and applicable law, compensation in a GLP-1 NAION lawsuit may include:

Medical expenses associated with diagnosis, specialist consultations, and ongoing care
Lost wages or reduced future earning capacity
Costs associated with vision rehabilitation or assistive technology
Pain, suffering, and emotional distress
Loss of enjoyment of life and diminished independence

The compensation available depends on the severity of the injury, the evidence supporting the claim, and the laws governing the case. No particular recovery is guaranteed.

How Long Do You Have to File a GLP-1 NAION Lawsuit in Alabama?

Alabama generally applies a two-year statute of limitations to many personal injury claims under Ala. Code § 6-2-38.

However, determining the deadline for a pharmaceutical injury lawsuit can be more complicated. The applicable filing period may depend on the type of claim, when the injury occurred, when the cause of action accrued, and other legal considerations.

Patients should not assume that the deadline automatically begins when they learn about a possible connection between their medication and NAION.

If you experienced vision loss after taking Ozempic, Wegovy, Rybelsus, or another GLP-1 medication, speaking with an attorney promptly can help you understand the deadlines that may apply to your circumstances.

How Can a Birmingham GLP-1 NAION Lawyer Help?

Pharmaceutical injury lawsuits often involve complex medical evidence, federal litigation procedures, and questions about whether manufacturers adequately disclosed known or potential risks.

An attorney familiar with dangerous drug claims can help evaluate these issues while you focus on your health and recovery.

At Morris Bart, our legal team can review your medication and medical history, examine the circumstances surrounding your NAION diagnosis, and explain whether pursuing legal action may be appropriate.

This process may include gathering prescription records, reviewing medical documentation, assessing the potential impact of your injury, and determining how ongoing GLP-1 litigation could affect your case.

Our Birmingham office serves individuals throughout the city, including Hoover, Homewood, Mountain Brook, Highland Park, Fairview, and surrounding communities.

Speak With a Birmingham GLP-1 NAION Attorney Today

If you or a loved one developed NAION after taking Ozempic, Wegovy, Rybelsus, or another GLP-1 medication, you may have questions about what caused your vision loss and whether you have legal options.

The Birmingham attorneys at Morris Bart are available to review your circumstances, explain the claims process, and help you determine the next steps.

Questions?Call 800-537-8185
to find a Morris Bart office near you.